Pfizer Inc (PFE)
28.82
+0.44
(+1.55%)
USD |
NYSE |
May 15, 16:00
28.90
+0.08
(+0.28%)
Pre-Market: 07:57
Pfizer Cash from Operations (Quarterly): 1.09B for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.09B |
December 31, 2023 | 5.24B |
September 30, 2023 | 3.456B |
June 30, 2023 | -1.208B |
March 31, 2023 | 1.212B |
December 31, 2022 | 8.582B |
September 30, 2022 | 5.974B |
June 30, 2022 | 8.17B |
March 31, 2022 | 6.541B |
December 31, 2021 | 5.914B |
September 30, 2021 | 10.83B |
June 30, 2021 | 11.30B |
March 31, 2021 | 4.538B |
December 31, 2020 | 5.625B |
September 30, 2020 | 2.09B |
June 30, 2020 | 3.555B |
March 31, 2020 | 3.133B |
December 31, 2019 | 3.769B |
September 30, 2019 | 4.51B |
June 30, 2019 | 2.611B |
March 31, 2019 | 1.698B |
December 31, 2018 | 4.738B |
September 30, 2018 | 5.259B |
June 30, 2018 | 3.847B |
March 31, 2018 | 1.983B |
Date | Value |
---|---|
December 31, 2017 | 7.089B |
September 30, 2017 | 4.889B |
June 30, 2017 | 3.24B |
March 31, 2017 | 1.584B |
December 31, 2016 | 6.041B |
September 30, 2016 | 4.737B |
June 30, 2016 | 3.606B |
March 31, 2016 | 1.808B |
December 31, 2015 | 4.898B |
September 30, 2015 | 5.02B |
June 30, 2015 | 4.09B |
March 31, 2015 | 680.00M |
December 31, 2014 | 5.599B |
September 30, 2014 | 4.463B |
June 30, 2014 | 4.087B |
March 31, 2014 | 2.935B |
December 31, 2013 | 5.724B |
September 30, 2013 | 5.90B |
June 30, 2013 | 3.757B |
March 31, 2013 | 2.303B |
December 31, 2012 | 4.948B |
September 30, 2012 | 5.003B |
June 30, 2012 | 4.021B |
March 31, 2012 | 2.774B |
December 31, 2011 | 5.261B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-1.208B
Minimum
Jun 2023
11.30B
Maximum
Jun 2021
4.846B
Average
4.524B
Median
Cash from Operations (Quarterly) Benchmarks
Amgen Inc | 689.00M |
Johnson & Johnson | 3.657B |
Eli Lilly and Co | 1.166B |
Viking Therapeutics Inc | -6.134M |
Moderna Inc | -989.00M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | 1.732B |
Cash from Financing (Quarterly) | -4.931B |
Free Cash Flow | 5.106B |
Free Cash Flow Per Share (Quarterly) | 0.0678 |
Free Cash Flow to Equity (Quarterly) | 2.523B |
Free Cash Flow to Firm (Quarterly) | 990.39M |
Free Cash Flow Yield | 3.12% |